National Addiction Centre, 4 Windsor Walk, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Department of Biostatistics and Health Informatics, Psychometrics and Measurement Lab, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London, UK.
Sleep. 2018 Apr 1;41(4). doi: 10.1093/sleep/zsy013.
To develop a patient-reported outcome measure to assess sleep amongst people experiencing problems with alcohol or other drugs.
Item development included secondary analyses of qualitative interviews with drug or alcohol users in residential treatment, a review of validated sleep measures, focus groups with drug or alcohol users in residential treatment, and feedback from drug or alcohol users recruited from community and residential settings. An initial version of the measure was completed by 549 current and former drug or alcohol users (442 in person and 107 online). Analyses comprised classical test theory methods, exploratory and confirmatory factor analysis, measurement invariance assessment, and item response theory (IRT).
The initial measure (30 items) had good content and face validity and was named the Substance Use Sleep Scale (SUSS) by addiction service users. After seven items were removed due to low item-factor loadings, two factors were retained and labeled: "Mind and Body Sleep Problems" (14 items) and "Substance-Related Sleep Problems" (nine items). Measurement invariance was confirmed with respect to gender, age, and administration format. IRT (information) and classical test theory (internal consistency and stability) indicated measure reliability. Standard parametric and nonparametric techniques supported convergent and discriminant validity.
SUSS is an easy-to-complete patient-reported outcome measure of sleep for people with drug or alcohol problems. It can be used by those concerned about their own sleep, and by treatment providers and researchers seeking to better understand, assess, and potentially treat sleep difficulties amongst this population. Further validity testing with larger and more diverse samples is now required.
开发一种患者报告结局测量工具,以评估有酒精或其他药物使用问题的人群的睡眠状况。
项目开发包括对住院治疗的药物或酒精使用者的定性访谈进行二次分析、对已验证的睡眠测量工具进行回顾、对住院治疗的药物或酒精使用者进行焦点小组讨论,以及对从社区和住院环境招募的药物或酒精使用者进行反馈。该测量工具的初始版本由 549 名现用和曾经使用过药物或酒精的人完成(442 人面对面完成,107 人在线完成)。分析包括经典测试理论方法、探索性和验证性因素分析、测量不变性评估和项目反应理论(IRT)。
初始测量工具(30 个项目)具有良好的内容和表面有效性,被成瘾服务使用者命名为物质使用睡眠量表(SUSS)。由于七个项目的项目-因子负荷较低而被删除后,保留了两个因子并进行了标记:“身心睡眠问题”(14 个项目)和“与物质相关的睡眠问题”(9 个项目)。性别、年龄和管理格式方面的测量不变性得到了确认。IRT(信息)和经典测试理论(内部一致性和稳定性)表明了测量的可靠性。标准参数和非参数技术支持了收敛性和区分效度。
SUSS 是一种针对有药物或酒精问题的人群的易于完成的睡眠患者报告结局测量工具。它可以由那些关注自身睡眠的人使用,也可以由治疗提供者和研究人员使用,以更好地了解、评估和潜在治疗该人群的睡眠困难。现在需要进一步用更大和更多样化的样本进行有效性测试。